BIO International Convention 2027

The BIO International Convention, run by the Biotechnology Innovation Organization, is the largest and most comprehensive event for the global biotechnology ecosystem. BIO returns to Philadelphia for its 2027 edition, bringing together pharma and biotech companies, investors, academics, patient advocates and government for four days of programming, company presentations, an exhibition and the BIO Partnering meeting system.

Who attends

BIO describes its audience as the full biotech ecosystem, with around 20,000 industry leaders from around the world at recent editions.

• Public pharmaceutical companies and biotech startups
• Business development professionals and investors
• Researchers and academia
• Non-profit organisations and patient advocates
• Government agencies and policymakers

BIO Partnering

BIO's proprietary partnering platform lets attendees schedule one-to-one meetings with potential partners and investors ahead of and during the convention. It is one of the main reasons companies attend.

2027 focus areas

The 2027 Call for Sessions, open until October 15, 2026, sets out the programme's focus areas.

• Artificial Intelligence
• Biomanufacturing and Supply Chains
• Business Development and Investment
• Cell and Gene Therapy and Genome Editing
• Chronic Diseases
• Global Health, Markets, and Resiliency
• Infectious Disease and Vaccines
• Intellectual Property and Legal Landscape
• Neuroscience
• Next Generation Biotherapeutics
• Oncology
• Orphan and Rare Diseases; Regulatory Innovation, Translational Research, and Value, Patient Access and Reimbursement

Formats

Recent editions combined an education programme with company presentations, an exhibition of more than 1,500 exhibitors (2026), curated programmes such as an AI Summit and Start-Up Stadium, a Patient Advocacy Pavilion and networking receptions.